Target intelligence / Profile preview

Ribosomal protein L13a pseudogene 14 (RPL13AP14)

Target: RPL13AP14
Molecular classification: Other, Pseudogene

Overview

Ribosomal protein L13a pseudogene 14 (RPL13AP14) is a non-coding pseudogene related to the RPL13A gene, which encodes a component of the 60S ribosomal subunit. While RPL13A is involved in protein synthesis and the repression of certain inflammatory mRNAs as part of the interferon-gamma-activated inhibitor of translation (GAIT) complex[7][3], RPL13AP14 does not encode a functional protein and is not considered a drug target or receptor of therapeutic interest[4][6]. Pseudogenes like RPL13AP14 are common in the genome and serve only as remnants of gene duplication or retrotransposition events.

Other names: RPL13A_3_590RPL13AP14

Beyond the preview

Go deeper on Ribosomal protein L13a pseudogene 14 (RPL13AP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L13a pseudogene 14 (RPL13AP14).

Explore the full profile